Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Dietary Supplements

365 SKINNY High Intensity Capsules Recalled for Undeclared Sibutramine

Agency Publication Date: February 16, 2022
Share:
Sign in to monitor this recall

Summary

Je Dois Lavoir LLC is recalling 783 bottles of 365 SKINNY High Intensity Capsules (600 mg, 30-count). Testing found the product contains sibutramine, an undeclared drug ingredient that was previously removed from the U.S. market due to safety concerns. These capsules were sold online through the manufacturer's website to consumers throughout the United States and Canada.

Risk

Sibutramine can significantly increase blood pressure and heart rate, posing a serious risk to individuals with a history of heart disease, heart failure, or stroke. No injuries or illnesses have been reported to date in connection with this recall.

What You Should Do

  1. This recall involves 30-count bottles of 365 SKINNY High Intensity Capsules (600 mg) from Body Balance Internacional, identified by lot number 102-26 and an expiration date of December 2022.
  2. If you have health concerns after using this product, contact your healthcare provider or pharmacist.
  3. Return any unused product to the place of purchase for a refund, throw it away, or contact Je Dois Lavoir LLC directly for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 for more information.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: 365 SKINNY High Intensity Capsulesby BODY BALANCE INTERNACIONAL
Variants: 600 mg, 30-count bottle
Lot Numbers:
102-26 (Exp Dec 2022)

Recall #: D-0631-2022

Product Images

Photo 1 โ€“ Labeling, 365 Skinny, High Intensity

Photo 1 โ€“ Labeling, 365 Skinny, High Intensity

Photo 2 โ€“ Labeling, 365 Skinny, Emergency Boutique

Photo 2 โ€“ Labeling, 365 Skinny, Emergency Boutique

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 88409
Status: Resolved
Manufacturer: Je Dois Lavoir LLC
Sold By: Online website
Manufactured In: United States
Units Affected: 783 bottles
Distributed To: Nationwide
Agency Last Updated: February 23, 2022

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท FDA Press Release (1) ยท FDA Press Release (2) ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.